fincash logo SOLUTIONS

Fincash » Search » Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd

Updated on July 11, 2024

Stock/Share Code - BAFNAPHARM

Bafna Pharmaceuticals is engaged in the business of Manufacturing of Pharmaceuticals.(Source : 201903 Annual Report Page No: 86)

Below is the details of BAFNAPHARM Bafna Pharmaceuticals Ltd

Market Cap₹8.4 Cr.
Current Price ₹3.55
52 Week High / Low Price₹14.7 / ₹3.55
Face Value₹10
Stock P/E
Book Value₹7.64
Dividend Yield0.00 %
ROCE-20.90 %
ROE-64.34 %
Sales Growth (3yrs)-20.14 %
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Stock is trading at 0.46 times its book value
Cons: Company has low interest coverage ratio. Promoter's stake has decreased The company has delivered a poor growth of -24.53% over past five years. Promoter holding is low: 26.36% Company has a low return on equity of -67.83% for last 3 years. Company might be capitalizing the interest cost Promoters have pledged 51.04% of their holding Company has high debtors of 209.02 days.

Bafna Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma ₹19.55 22.45 ₹8,699.08 Cr. 0.91 ₹116.36 Cr. -6.59 18.13 642.76 23.85
2. 20.38 ₹6,338.29 Cr. 0.00 ₹92.71 Cr. 8.66 7.81 284.80 26.43
3. Caplin Point Lab 11.70 ₹2,375.18 Cr. 0.70 ₹57.27 Cr. 31.66 45.77 227.20 48.53
4. Bliss GVS Pharma 13.64 ₹1,482.58 Cr. 0.70 ₹30.98 Cr. -25.28 -8.02 210.12 26.90
5. Hester Bios 32.62 ₹1,333.11 Cr. 0.70 ₹6.52 Cr. -6.46 3.34 44.20 26.65
6. Amrutanjan Healt 47.87 ₹1,304.86 Cr. 0.48 ₹8.4 Cr. 29.43 20.56 74.81 25.42
7. Medicamen Biotec 30.33 ₹374.93 Cr. 0.31 ₹3.84 Cr. 7.87 9.33 35.52 20.15
8. Bafna Pharma. ₹8.4 Cr. 0.00 -₹0.59 Cr. 53.91 30.88 11.57 -20.90

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Bafna Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
YOY Sales Growth %-20.32%-39.57%-56.99%-35.23%-31.61%4.03%31.32%-17.23%20.35%-42.55%-42.68%30.88%
Material Cost %87.47%87.47%109.45%72.75%70.9%111.8%92.38%63.91%68.17%94.52%92.7%76.58%
Employee Cost %9.95%9.95%17.36%16.67%16.76%13.86%16.23%24.66%16.99%28.13%33.72%21%
Operating Profit-0.13-0.13-
OPM %-0.82%-0.82%-33.85%2.62%5.06%-198.79%-15.23%2.04%8.95%-134.98%-41.75%-3.28%
Other Income0.780.780.070.0030.260.930.09-0.030.310.280.300.59
Profit before tax-3.50-3.50-5.91-2.7628.09-33.70-3.56-1.220.12-13.51-3.71-0.55
Tax %1.43%1.43%-28.76%-0.36%0.00%-1.39%1.12%-4.10%0.00%-11.03%42.59%-7.27%
Net Profit-3.44-3.44-7.61-2.7728.09-34.17-3.51-1.280.12-15.00-2.13-0.59
EPS in Rs-1.85-1.85-4.08-1.4815.06-14.44-1.49-0.540.05-6.34-0.90-0.25

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales Growth %15.76%16.49%62.47%36.19%22.09%34.84%6.16%-43.29%-15.22%-23.68%-29.86%-4.83%%
Material Cost %89.39%77.41%79.34%78.36%72.53%73.42%70.42%84.58%75.98%79.93%84.02%64.14%%
Manufacturing Cost %2.14%4.94%4.22%4.12%3.66%2.41%3.04%9.21%7.88%8.61%12.45%16.1%%
Employee Cost %1.4%3.39%3.16%3.05%4.58%6.36%7.82%10.3%7.57%10.19%16.4%20.78%%
Other Cost %2.19%4.24%3.5%3.14%4.35%5.24%6.73%14.28%5.27%9.3%64.14%29.73%%
Operating Profit1.924.597.2811.4818.4120.9721.22-18.452.81-5.21-35.08-13.33-14.88
OPM %4.89%10.03%9.79%11.33%14.89%12.57%11.99%-18.38%3.30%-8.02%-77.00%-30.74%-36.31%
Other Income0.301.450.780.620.923.031.4042.251.241.1431.260.651.48
Profit before tax1.302.614.005.035.365.182.236.08-12.53-19.30-14.28-18.23-17.65
Tax %7.69%59.00%38.00%33.40%61.38%25.10%39.91%-0.49%2.71%4.35%-15.27%-8.23%
Net Profit1.201.072.483.352.073.881.346.11-12.18-18.47-16.45-19.73-17.60
EPS in Rs0.671.551.921.131.980.723.
Dividend Payout %0.00%0.00%0.00%0.00%0.00%28.86%0.00%0.00%-0.00%-0.00%-0.00%-0.00%

Compounded Sales Growth

  • 10 Years:: -0.54%
  • 5 Years:: -24.53%
  • 3 Years:: -20.14%
  • TTM:: -14.93%

Compounded Profit Growth

  • 3 Years:: -27.56%
  • TTM:: -61.91%

Return on Equity

  • 10 Years:: -20.39%
  • 5 Years:: -36.43%
  • 3 Years:: -51.59%
  • 1 Year:: -72.16%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital9.5815.9815.9817.4818.3818.6618.6618.6618.6618.6623.6623.6623.66
Equity Capital9.5815.9815.9817.4818.3818.6618.6618.6618.6618.6623.6623.6623.66
Other Liabilities14.4815.4013.3333.1368.6887.5854.4749.9345.0043.7940.4453.6157.39
Trade Payables12.8612.989.8425.4853.172.0939.4834.6529.9323.427.8239.4244.61
Total Liabilities51.1377.8384.13135.62207.35242.94222.59185.26184.93167.15127.51120.64122.47
Fixed Assets2.3433.7032.1333.3869.8266.4062.9348.6346.9943.3239.9437.0235.65
Gross Block4.4237.1537.3240.8481.6483.3585.170.1472.4472.4172.5472.87
Accumulated Depreciation2.083.455.197.4611.8216.9622.1621.5125.4429.0932.635.85
Other Assets19.0340.9445.6188.58136.10175.11158.23118.30119.61105.5086.1482.1985.39
Trade receivables10.0924.2620.3334.9881.6385.4793.183.3667.8953.724.2824.8327.17
Cash Equivalents1.192.031.8411.782.320.722.472.452.72.662.72.72.46
Loans n Advances2.127.9612.5925.8525.1840.0826.716.2931.953.7510.6311.4232.27
Other Assets etc0.262.031.511.224.417.799.240.870.7228.6537.8633.9612.31
Total Assets51.1377.8384.13135.62207.35242.94222.59185.26184.93167.15127.51120.64122.47

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity-2.09-13.98-0.59-6.3527.5635.400.769.47-2.9713.70-7.10-1.10
Profit from operations2.185.88.3411.5215.3120.9721.21-18.452.82-10.33-34.18-12.81
Working Capital Changes-4.16-19.48-8.43-17.0913.315.29-20.0230.18-5.7924.0327.0911.71
Taxes paid-0.11-0.3-0.5-0.78-1.05-0.86-0.43-2.260000
Cash from Investing Activity-6.89-5.54-3.17-10.50-36.52-5.70-4.9056.43-1.09-8.3037.793.53
Fixed Assets Purchased-0.2-32.74-0.17-3.51-27.14-1.72-1.75-7.72-2.29-0.08-0.13-0.33
Fixed Assets Sold0000000006.0746.940
Capital WIP-0.6217.74-3.2-7.2700000000
Investments sold000000056.20000
Cash from Financing Activity8.4020.363.5726.79-0.51-11.29-14.11-65.924.31-5.43-30.65-2.44
Proceeds from Shares1.5225.609.847.630.97000000
Proceeds from Borrowings7.6807.0621.2900.260.05024.783.8400
Repayment of Borrowings0-0.89-1.17-0.0400-2.1-36.54-8-1.93-35.84-0.31
Interest Paid-0.57-2.06-2.320-8.14-11.22-12.06-12.48-12.47-11.34-6.81-2.13
Dividends Paid000-4.30-1.3000000
Net Cash Flow-0.580.84-0.199.94-9.4718.41-18.25-0.020.25-

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %6.29%9.43%9.49%10.77%11.30%9.54%8.84%-13.09%-0.04%-6.05%-35.65%-20.90%
Debtor Days93.71193.4299.76126.04240.90187.06191.93303.05291.12301.73194.52209.02
Inventory Turnover6.599.1310.638.416.637.647.414.785.373.933.324.35

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Bafna Pharmaceuticals Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.